2025年全球藥物釋放型球囊導管市場報告

預計未來幾年藥物釋放型球囊導管市場將快速成長。到 2029 年，這一數字將成長至 26.1 億美元，複合年成長率為 12.0%。預測期內的成長可歸因於呼吸系統疾病的持續成長、老年人口的擴大、認知和教育的提高、新興國家的市場擴張、定製藥物配方、監管支持和合規以及包裝和設計創新。預測期內的主要趨勢包括智慧吸入器和連接性、向呼吸驅動吸入器的轉變、關注兒科和老年患者的需求、生技藥品輸送以及環保吸入器設計。

預計周邊疾病和心血管疾病的日益普及將在未來幾年推動藥物釋放型球囊導管市場的成長。心血管疾病 (CVD) 包括影響心臟和循環系統的多種疾病，而周邊動脈疾病(PAD) 則涉及動脈變窄，導致血流減少，主要流向手臂和腿部。藥物釋放型球囊導管用於治療冠狀動脈疾病 (CAD)，其特徵是半相容血管成形術用氣球塗有抗增殖藥物，一旦進入血管即可提供抗血管再阻塞作用。例如，美國政府機構美國疾病管制與預防中心（CDC）在2024年5月報告稱，心臟病將在2022年導致702,880人死亡，佔死亡人數的五分之一。美國每年約有 805,000 人心臟病發作，其中約 605,000 人是首次心臟病發作，20 萬人之前曾有心臟病發作。因此，周邊疾病和心血管疾病盛行率的上升正在推動藥物釋放型球囊導管市場的發展。

預計對微創手術的需求不斷成長將進一步推動藥物釋放型球囊導管市場的成長。微創手術是一種切口較小的手術技術，可縮短癒合時間、減少疼痛並降低感染風險。藥物釋放型球囊在這些治療中至關重要，它可以將藥物直接輸送到治療部位，防止血管再阻塞並提高血管干預的有效性。例如，Intuitive Surgical Inc. 報告稱，使用其 Vinci 手術系統的手術數量將從 2021 年的 1,594,000 例增加 18% 至 2022 年的 1,875,000 例。此外，美國整形外科醫師協會指出，到 2022 年，美國的微創美容手術將增加到 23,672,269 例。因此，對微創手術的需求不斷成長正在推動藥物釋放型球囊導管市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球藥物釋放型球囊導管PESTEL分析（政治、社會、技術、環境、法律、促進因素、限制因素）
• 最終用途產業分析
• 全球藥物釋放型球囊導管市場：成長率分析
• 全球藥物釋放型球囊導管市場表現：規模與成長，2019-2024
• 全球藥物釋放型球囊導管市場預測：規模與成長，2024-2029 年，2034 年
• 全球藥物釋放型球囊導管總目標市場（TAM）

第6章市場區隔

• 全球藥物釋放型球囊導管市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 冠狀動脈疾病藥物釋放型球囊導管
• 周邊血管疾病藥物釋放型球囊導管
• 全球藥物釋放型球囊導管市場（依藥物、實際及預測），2019-2024 年、2024-2029 年、2034 年
• 紫杉醇
• Sirolimus
• 其他藥物
• 全球藥物釋放型球囊導管市場：按材料、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 尼龍
• 聚氨酯
• 其他成分
• 全球藥物釋放型球囊導管市場：依最終使用者、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 醫院和診所
• 門診手術中心
• 導管室
• 全球藥物釋放型球囊導管市場，按冠狀動脈疾病細分，按類型、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 藥物釋放型球囊導管
• 一般球囊導管
• 全球藥物釋放型球囊導管市場、周邊血管疾病細分市場、類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
• 藥物釋放型球囊導管
• 血管成形術用氣球導管
• 全球藥物釋放型球囊導管市場、血管成形術用氣球導管細分、類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
• 藥物釋放型血管成形術用氣球導管

第7章 區域和國家分析

• 全球藥物釋放型球囊導管市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球藥物釋放型球囊導管市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 藥物釋放型球囊導管市場：競爭格局
• 藥物釋放型球囊導管市場：公司簡介
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• B Braun Melsungen Aktiengesellschaft
• Terumo Corporation
• Cook Medical LLC
• Lepu Medical Technology Co. Ltd.
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• BIOTRONIK SE & Co. KG
• Acotec Scientific Co. Ltd.
• Cordis Corporation
• Biosensors International Group Ltd.
• Zylox-Tonbridge Medical Technology Co. Ltd.
• Mermaid Medical AS
• Hexacath Limited
• Zhejiang Barty Medical Technology Co. Ltd.
• Cardionovum GmbH

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年藥物釋放型球囊導管市場：提供新機會的國家
• 2029年藥物釋放型球囊導管市場：細分領域帶來新機會
• 2029年藥物釋放型球囊導管市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

A drug-eluting balloon catheter is a medical device utilized in the treatment of coronary artery disease through percutaneous coronary intervention (PCI). It is a semi-compliant angioplasty balloon that is coated with an anti-proliferative drug. During inflation, the drug is released into the vessel wall, aiming to prevent restenosis and reduce the risk of late thrombosis without the need for implanting a permanent foreign object.

The main types of drug-eluting balloon catheters include those designed for coronary artery disease and peripheral vascular disease. Coronary artery disease drug-eluting balloon catheters deliver antiproliferative drugs directly to the vessel wall using a lipophilic matrix, eliminating the need for a permanent structure such as a metal prosthesis or persistent polymer. Various drugs such as paclitaxel and sirolimus are used, and the catheters are made from raw materials such as nylon, polyurethane, and others. They find applications in hospitals, clinics, ambulatory surgical centers, and catheterization laboratories.

The drug eluting balloons catherers market research report is one of a series of new reports from The Business Research Company that provides drug eluting balloons catherers market statistics, including drug eluting balloons catherers industry global market size, regional shares, competitors with a drug eluting balloons catherers market share, detailed drug eluting balloons catherers market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting balloons catherers industry. This drug eluting balloons catherers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug eluting balloons catheters market size has grown rapidly in recent years. It will grow from $1.43 billion in 2024 to $1.66 billion in 2025 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to increasing respiratory disorders, advantages over traditional inhalers, patient preference for dpis, government initiatives for respiratory health, strategic collaborations and partnerships, advancements in drug formulations, rising geriatric population.

The drug eluting balloons catheters market size is expected to see rapid growth in the next few years. It will grow to $2.61 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to continued growth in respiratory disorders, expanding geriatric population, increasing awareness and education, market expansion in emerging economies, customized drug formulations, regulatory support and compliance, innovations in packaging and design. Major trends in the forecast period include smart inhalers and connectivity, shift towards breath-actuated inhalers, focus on pediatric and geriatric patient needs, biologics delivery, environmentally friendly inhaler designs.

The increasing prevalence of peripheral and cardiovascular diseases is anticipated to drive the growth of the drug-eluting balloon catheter market in the future. Cardiovascular diseases (CVDs) encompass a range of conditions affecting the heart and circulatory system, while peripheral artery disease (PAD) specifically involves the narrowing of arteries that diminishes blood flow mainly to the arms or legs. Drug-eluting balloon catheters are utilized in the treatment of coronary artery disease (CAD); they feature a semi-compliant angioplasty balloon coated with an anti-proliferative agent that exerts an anti-restenotic effect upon entering the vessel. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that in 2022, heart disease was responsible for 702,880 deaths, representing 1 in every 5 fatalities. Annually, around 805,000 individuals in the United States suffer a heart attack, with approximately 605,000 being their first heart attack and 200,000 occurring in those who have previously experienced one. Thus, the rising prevalence of peripheral and cardiovascular diseases is propelling the drug-eluting balloon catheter market.

The increasing demand for minimally invasive procedures is expected to further propel the growth of the drug-eluting balloon catheter market. Minimally invasive procedures involve surgical techniques with small incisions, resulting in reduced healing time, less pain, and lower infection risks. Drug-eluting balloons are crucial in these procedures, delivering medication directly to the treatment area to prevent restenosis and enhance the effectiveness of vascular interventions. For instance, Intuitive Surgical Inc. reported an 18% increase in surgical procedures using Vinci surgical systems from 1,594,000 in 2021 to 1,875,000 in 2022. Additionally, the American Society of Plastic Surgeons noted a rise in cosmetic minimally invasive procedures in the US to 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the drug-eluting balloon catheter market.

Key players in the drug-eluting balloon catheter market are intensifying their efforts to develop next-generation products with advanced technologies to secure a competitive advantage. For instance, in March 2024, Boston Scientific Corporation, a U.S.-based biomedical and biotechnology engineering firm, announced it had received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB). This product is the first drug-coated coronary balloon available in the U.S. specifically designed for treating in-stent restenosis (ISR), a condition where plaque or scar tissue obstructs a previously stented vessel. The AGENT DCB features a paclitaxel coating that provides a therapeutic dose to the vessel wall, effectively reducing ISR recurrence without the need for additional stents or radiation. Clinical trials demonstrated a 49% reduction in the risk of heart attack at the target site, along with low rates of adverse events.

In June 2023, Translumina Therapeutics Company acquired Blue Medical Devices BV for an undisclosed amount. This strategic acquisition aimed to integrate Blue Medical's unique drug application technology into Translumina's product lines, expanding offerings in neurovascular and peripheral interventions and enhancing drug coating capabilities. Blue Medical Devices BV is a Netherlands-based medical device company specializing in producing drug-eluting balloon catheters.

Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB

North America was the largest region in the drug eluting balloons catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug-eluting balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug-eluting balloon catheter market consists of sales of everolimus and stellarex. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Eluting Balloons Catheters Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug eluting balloons catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug eluting balloons catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug eluting balloons catheters market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters; Peripheral Vascular Disease Drug-Eluting Balloon Catheters
• 2) By Drug: Paclitaxel; Sirolimus; Other Drugs
• 3) By Raw Material: Nylon; Polyurethane; Other Raw Materials
• 4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Catheterization Laboratories
• Subsegments:
• 1) By Coronary Artery Disease: Drug-Eluting Balloon Catheters; Plain Balloon Catheters
• 2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters; Angioplasty Balloon Catheters
• 3) By Angioplasty Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters
• Companies Mentioned: Abbott Laboratories; Medtronic PLC; Becton Dickinson and Company; Koninklijke Philips NV; Boston Scientific Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Eluting Balloons Catheters Market Characteristics

3. Drug Eluting Balloons Catheters Market Trends And Strategies

4. Drug Eluting Balloons Catheters Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Drug Eluting Balloons Catheters Growth Analysis And Strategic Analysis Framework

• 5.1. Global Drug Eluting Balloons Catheters PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Drug Eluting Balloons Catheters Market Growth Rate Analysis
• 5.4. Global Drug Eluting Balloons Catheters Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Drug Eluting Balloons Catheters Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Drug Eluting Balloons Catheters Total Addressable Market (TAM)

6. Drug Eluting Balloons Catheters Market Segmentation

• 6.1. Global Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coronary Artery Disease Drug-Eluting Balloon Catheters
• Peripheral Vascular Disease Drug-Eluting Balloon Catheters
• 6.2. Global Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Paclitaxel
• Sirolimus
• Other Drugs
• 6.3. Global Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nylon
• Polyurethane
• Other Raw Materials
• 6.4. Global Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Ambulatory Surgical Centers
• Catheterization Laboratories
• 6.5. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Coronary Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Eluting Balloon Catheters
• Plain Balloon Catheters
• 6.6. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Peripheral Vascular Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Eluting Balloon Catheters
• Angioplasty Balloon Catheters
• 6.7. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Angioplasty Balloon Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Eluting Angioplasty Balloon Catheters

7. Drug Eluting Balloons Catheters Market Regional And Country Analysis

• 7.1. Global Drug Eluting Balloons Catheters Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Drug Eluting Balloons Catheters Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Eluting Balloons Catheters Market

• 8.1. Asia-Pacific Drug Eluting Balloons Catheters Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Eluting Balloons Catheters Market

• 9.1. China Drug Eluting Balloons Catheters Market Overview
• 9.2. China Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Eluting Balloons Catheters Market

• 10.1. India Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Eluting Balloons Catheters Market

• 11.1. Japan Drug Eluting Balloons Catheters Market Overview
• 11.2. Japan Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Eluting Balloons Catheters Market

• 12.1. Australia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Eluting Balloons Catheters Market

• 13.1. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Eluting Balloons Catheters Market

• 14.1. South Korea Drug Eluting Balloons Catheters Market Overview
• 14.2. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Eluting Balloons Catheters Market

• 15.1. Western Europe Drug Eluting Balloons Catheters Market Overview
• 15.2. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Eluting Balloons Catheters Market

• 16.1. UK Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Eluting Balloons Catheters Market

• 17.1. Germany Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Eluting Balloons Catheters Market

• 18.1. France Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Eluting Balloons Catheters Market

• 19.1. Italy Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Eluting Balloons Catheters Market

• 20.1. Spain Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Eluting Balloons Catheters Market

• 21.1. Eastern Europe Drug Eluting Balloons Catheters Market Overview
• 21.2. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Eluting Balloons Catheters Market

• 22.1. Russia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Eluting Balloons Catheters Market

• 23.1. North America Drug Eluting Balloons Catheters Market Overview
• 23.2. North America Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Eluting Balloons Catheters Market

• 24.1. USA Drug Eluting Balloons Catheters Market Overview
• 24.2. USA Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Eluting Balloons Catheters Market

• 25.1. Canada Drug Eluting Balloons Catheters Market Overview
• 25.2. Canada Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Eluting Balloons Catheters Market

• 26.1. South America Drug Eluting Balloons Catheters Market Overview
• 26.2. South America Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Eluting Balloons Catheters Market

• 27.1. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Eluting Balloons Catheters Market

• 28.1. Middle East Drug Eluting Balloons Catheters Market Overview
• 28.2. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Eluting Balloons Catheters Market

• 29.1. Africa Drug Eluting Balloons Catheters Market Overview
• 29.2. Africa Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Eluting Balloons Catheters Market Competitive Landscape And Company Profiles

• 30.1. Drug Eluting Balloons Catheters Market Competitive Landscape
• 30.2. Drug Eluting Balloons Catheters Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Drug Eluting Balloons Catheters Market Other Major And Innovative Companies

• 31.1. B Braun Melsungen Aktiengesellschaft
• 31.2. Terumo Corporation
• 31.3. Cook Medical LLC
• 31.4. Lepu Medical Technology Co. Ltd.
• 31.5. Meril Life Sciences Pvt. Ltd.
• 31.6. MicroPort Scientific Corporation
• 31.7. BIOTRONIK SE & Co. KG
• 31.8. Acotec Scientific Co. Ltd.
• 31.9. Cordis Corporation
• 31.10. Biosensors International Group Ltd.
• 31.11. Zylox-Tonbridge Medical Technology Co. Ltd.
• 31.12. Mermaid Medical AS
• 31.13. Hexacath Limited
• 31.14. Zhejiang Barty Medical Technology Co. Ltd.
• 31.15. Cardionovum GmbH

32. Global Drug Eluting Balloons Catheters Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Eluting Balloons Catheters Market

34. Recent Developments In The Drug Eluting Balloons Catheters Market

35. Drug Eluting Balloons Catheters Market High Potential Countries, Segments and Strategies

• 35.1 Drug Eluting Balloons Catheters Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Drug Eluting Balloons Catheters Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Drug Eluting Balloons Catheters Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer